Post

Regeneron and Intellia expand partnership to develop CRISPR-based therapies

Regeneron Pharmaceuticals has entered an expanded research collaboration with Intellia Therapeutics to develop clustered, regularly interspaced, short palindromic repeats (CRISPR)-based …

FDA grants EUA for Novavax’s updated Covid-19 vaccine 

The US Food and Drug Administration (FDA) has amended the emergency use authorisation of Novavax’s adjuvanted Covid-19 vaccine (NVX-CoV2601) to …

Lilly agrees to buy POINT Biopharma for $1.4bn

Eli Lilly and Company has signed a definitive agreement for the acquisition of all outstanding shares of radiopharmaceutical company POINT …

WHO’s SAGE recommends Takeda’s dengue vaccine

The World Health Organisation’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended Takeda’s QDENGA (dengue tetravalent vaccine [live, attenuated]) …

Nitric oxide by NOxy Health Products for Diabetic Foot Ulcers: Likelihood of Approval

Nitric oxide is under clinical development by NOxy Health Products and currently in Phase I for Diabetic Foot Ulcers. According …